152 related articles for article (PubMed ID: 32319655)
1. TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease.
Zhu F; Qiu T; Zhu S; Zhao K; Chen C; Qiao J; Pan B; Yan Z; Chen W; Liu Q; Wu Q; Cao J; Sang W; Zeng L; Sun H; Li Z; Xu K
Oncol Rep; 2020 Jul; 44(1):43-54. PubMed ID: 32319655
[TBL] [Abstract][Full Text] [Related]
2. TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
Frischer JM; Reindl M; Künz B; Berger T; Schmidt S; Milford EL; Knosp E; Lassmann H; Utku N
Mult Scler; 2014 Aug; 20(9):1171-81. PubMed ID: 24526664
[TBL] [Abstract][Full Text] [Related]
3. T-cell immune response cDNA 7 in allograft rejection and inflammation.
Utku N; Heinemann T; Milford EL
Curr Opin Investig Drugs; 2007 May; 8(5):401-10. PubMed ID: 17520869
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T Lymphocyte Antigen-4 Down-Regulates T Helper 1 Cells by Increasing Expression of Signal Transducer and Activator of Transcription 3 in Acute Graft-versus-Host Disease.
Zhu F; Zhong XM; Qiao J; Liu Q; Sun HY; Chen W; Zhao K; Wu QY; Cao J; Sang W; Yan ZL; Zeng LY; Li ZY; Xu KL
Biol Blood Marrow Transplant; 2016 Feb; 22(2):212-219. PubMed ID: 26555814
[TBL] [Abstract][Full Text] [Related]
5. TIRC7 pathway as a target for preventing allograft rejection.
Tamura A; Milford EL; Utku N
Drug News Perspect; 2005 Mar; 18(2):103-8. PubMed ID: 15883619
[TBL] [Abstract][Full Text] [Related]
6. TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
Bulwin GC; Heinemann T; Bugge V; Winter M; Lohan A; Schlawinsky M; Schulze A; Wälter S; Sabat R; Schülein R; Wiesner B; Veh RW; Löhler J; Blumberg RS; Volk HD; Utku N
J Immunol; 2006 Nov; 177(10):6833-41. PubMed ID: 17082597
[TBL] [Abstract][Full Text] [Related]
7. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP).
Zhu F; Qiao J; Cao J; Sun HY; Wu QY; Sun ZT; Zhao K; Sang W; Qi KM; Zeng LY; Li ZY; Xu KL
Thromb Res; 2015 Oct; 136(4):797-802. PubMed ID: 26272303
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of T cell immune response cDNA 7 in patients with acute graft-versus-host disease.
Zhu F; Qiao J; Chen W; Pan B; Wu QY; Cao J; Sang W; Yan ZL; Zeng LY; Li ZY; Xu KL
Ann Hematol; 2015 Jun; 94(6):1025-32. PubMed ID: 25623380
[TBL] [Abstract][Full Text] [Related]
9. TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response.
Utku N; Boerner A; Tomschegg A; Bennai-Sanfourche F; Bulwin GC; Heinemann T; Loehler J; Blumberg RS; Volk HD
J Immunol; 2004 Aug; 173(4):2342-52. PubMed ID: 15294947
[TBL] [Abstract][Full Text] [Related]
10. Role of T cell immune response cDNA 7 on the pathology of acute graft-versus-host disease.
Zhu F; Xu Y; Fan X; Zhang F; Wang D; Qiao J; Zhu S; Zhao K; Pan B; Chen C; Zeng L; Li Z; Xu K
Oncol Lett; 2020 Dec; 20(6):300. PubMed ID: 33101494
[TBL] [Abstract][Full Text] [Related]
11. Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia.
Zhu F; Qiao J; Zhong XM; Wu QY; Chen W; Yao Y; Niu MS; Fu CL; Zeng LY; Li ZY; Xu KL
Med Oncol; 2015 Jul; 32(7):197. PubMed ID: 26049920
[TBL] [Abstract][Full Text] [Related]
12. TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats.
Kumamoto Y; Tamura A; Volk HD; Reinke P; Löhler J; Tullius SG; Utku N
Transpl Immunol; 2006 Nov; 16(3-4):238-44. PubMed ID: 17138060
[TBL] [Abstract][Full Text] [Related]
13. CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.
Herrmann A; Priceman SJ; Swiderski P; Kujawski M; Xin H; Cherryholmes GA; Zhang W; Zhang C; Lahtz C; Kowolik C; Forman SJ; Kortylewski M; Yu H
J Clin Invest; 2014 Jul; 124(7):2977-87. PubMed ID: 24892807
[TBL] [Abstract][Full Text] [Related]
14. Characterization of IL-10-secreting T cells derived from regulatory CD4+CD25+ cells by the TIRC7 surface marker.
Wakkach A; Augier S; Breittmayer JP; Blin-Wakkach C; Carle GF
J Immunol; 2008 May; 180(9):6054-63. PubMed ID: 18424726
[TBL] [Abstract][Full Text] [Related]
15. Monocytes differentiation upon treatment with a peptide corresponding to the C-terminus of activated T cell-expressed Tirc7 protein.
Mouline CC; Beranger GE; Schmid-Antomarchi H; Quincey D; Momier D; Boukhechba F; Carle GF; Rochet N; Scimeca JC
J Cell Physiol; 2012 Aug; 227(8):3088-98. PubMed ID: 22015593
[TBL] [Abstract][Full Text] [Related]
16. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein.
Utku N; Heinemann T; Tullius SG; Bulwin GC; Beinke S; Blumberg RS; Beato F; Randall J; Kojima R; Busconi L; Robertson ES; Schülein R; Volk HD; Milford EL; Gullans SR
Immunity; 1998 Oct; 9(4):509-18. PubMed ID: 9806637
[TBL] [Abstract][Full Text] [Related]
17. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
18. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
[TBL] [Abstract][Full Text] [Related]
19. CD28-specific antibody prevents graft-versus-host disease in mice.
Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
[TBL] [Abstract][Full Text] [Related]
20. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A; Lahtz C; Nagao T; Song JY; Chan WC; Lee H; Yue C; Look T; Mülfarth R; Li W; Jenkins K; Williams J; Budde LE; Forman S; Kwak L; Blankenstein T; Yu H
Cancer Res; 2017 Sep; 77(18):5118-5128. PubMed ID: 28716895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
